The Automatic blood plasma clamp market is segmented by Application into diagnostic laboratories, blood banks, transfusion centers, and clinical research facilities. Diagnostic laboratories dominate the segment, accounting for ~45% of market demand due to routine plasma testing and sample processing requirements. Blood banks contribute ~30%, driven by the need for standardized plasma handling during donation and storage. Transfusion centers, though smaller (~15%), are critical for emergency plasma management, while clinical research facilities (~10%) show high growth potential due to R&D investments in hematology. These applications collectively define the market taxonomy, with healthcare infrastructure expansion and regulatory compliance shaping adoption rates.